RSV Vaccine - Synexus

Respiratory Syncytial Virus (RSV) Vaccines

We are currently looking for study participants for clinical trials of RSV vaccines.

If eligible, your participation includes trial-related care from local doctors and specialists.

012 004 2696

Just takes a few minutes.

RESPIRATORY SYNCYTIAL VIRUS CAN BE DANGEROUS FOR OLDER ADULTS.

HELP VACCINE RESEARCH.

Respiratory syncytial virus (RSV) is a common, highly contagious virus that usually causes mild, cold-like symptoms. While many people recover in a week or two, the virus can be dangerous to older people and infants.

RS virus can cause serious illness in older adults, especially those with heart or lung diseases such as COPD, asthma, or heart failure; or weakened immune systems. As of now, there are no approved vaccines for this virus.

Scientists are working to change that. We are looking for clinical trial volunteers aged 60 and over to help us test investigational vaccines for respiratory syncytial virus that are not available from your regular doctor.

WHAT ARE CLINICAL TRIALS?

Clinical trials are medical research studies that test investigational medicines and treatments.

People may not give much thought to clinical research, but everything from aspirin to chemotherapy has been carefully tested before being prescribed by your doctor.

Clinical trials need human volunteers, who participate under the supervision of a doctor and/or health professionals. As the trial goes on, the doctors gather more and more information about the medicine or treatment under investigation. It is only through clinical trials that we learn if medicines and treatments are both effective and safe.

All Synexus Trials are approved by SAHPRA and a Research Ethics Committee.

Take the next step and find out if you are eligible to participate in a local respiratory syncytial virus vaccine clinical trial.